Merck KGaA

Procter & Gamble to buy the consumer health business of Merck KGaA for $4.2 bn

Nestle, Bain Capital, Cinven in race for Merck KgaA's consumer health unit

Merck KGaA mulls splitting into three companies

Fresenius to buy Merck's biosimilars business for as much as €670 mn

US FDA approves Merck KGaA and Pfizer drug for rare skin cancer

Merck overhauls brand identity to communicate new direction

Merck KGaA extends buyout offer period for AZ Electronic Materials

Dr. Reddy's Laboratories, Merck Serono to develop biosimilars

Merck to pay Threshold up to $525 million for cancer drug development

Merck KGaA sells women's health business to Teva for €285 million

Merck KGaA beats Thermo Fisher to acquire Millipore for $7.2 billion

Merck KGaA acquires Banagalore bioscience firm

Mylan Inc. acquires Merck KGaA's central eastern European generics businesses

BASF, Bosch, Merck, Schott in organic photovoltaics

Mylan Laboratories to acquire Merck generics unit for $6.6 billion

Is Torrent a serious contender for Merck?

Private equity firms' bid plans boosts Merck group shares

Aurigene, Merck Serono collaborate on therapeutics for autoimmune disorders

Merck pays Glenmark Rs148 crore upfront for diabetes drug